GSK, Reckitt are the Only Suitors for Pfizer's $20B Consumer Health Biz Post author:Sam Post published:February 4, 2018 Post category:BioPharma Companies including Sanofi, J&J, Nestle have dropped out. Source: BioSpace You Might Also Like Bay Area's Coherus Dealt Another Blow as Daiichi Sankyo Discontinues Work on RA Drug July 4, 2017 What You Need to Know About DMD Therapeutics January 29, 2018 This One Drugmaker Has Paid Dividends the Past 120+ Years May 3, 2017
